UroGen Pharma Ltd URGN
$27.65 −$4.08 (-12.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.65 0.00%
Open$31.15
Prev close$31.73
Day range$27.57 – $31.90
Volume2.40M
Market cap$1.36B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts5
Average target$62.20+125.0% vs. price
- Buy 100%
Low $56.00Now $27.65Avg $62.20High $75.00
Recent rating changes
The last 20 actions on file set price targets from $42.00 to $75.00, averaging $62.10.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Piper Sandler | BUY | $58.00 |
| 5 Nov 2026 | Ladenburg Thalmann | BUY | $62.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $75.00 |
| 5 Nov 2026 | Oppenheimer | BUY | $60.00 |
| 4 Nov 2026 | Guggenheim | BUY | $56.00 |
| 3 Nov 2026 | H.C. Wainwright | BUY | $75.00 |
| 28 Oct 2026 | Oppenheimer | BUY | $60.00 |
| 19 Oct 2026 | Guggenheim | BUY | $58.00 |
| 19 Oct 2026 | H.C. Wainwright | BUY | $75.00 |
| 21 Aug 2026 | H.C. Wainwright | BUY | $75.00 |
| 20 Aug 2026 | H.C. Wainwright | BUY | $75.00 |
| 11 Aug 2026 | H.C. Wainwright | BUY | $75.00 |
| 6 Aug 2026 | H.C. Wainwright | BUY | $75.00 |
| 6 Aug 2026 | Oppenheimer | BUY | $60.00 |
| 5 Aug 2026 | TD Cowen | BUY | $60.00 |
| 5 Aug 2026 | Goldman Sachs | HOLD | $48.00 |
| 5 Aug 2026 | Guggenheim | BUY | $58.00 |
| 21 Jul 2026 | Guggenheim | BUY | $42.00 |
| 20 Jul 2026 | TD Cowen | BUY | $50.00 |
| 16 Jul 2026 | H.C. Wainwright | BUY | $45.00 |
No comments yet — be the first to weigh in on URGN.
Sign in to join the discussion.